Literature DB >> 19424709

Minimally invasive total hip arthroplasty: a randomized controlled prospective trial.

Farhad Mazoochian1, Patrick Weber, Sara Schramm, Sandra Utzschneider, Andreas Fottner, Volkmar Jansson.   

Abstract

INTRODUCTION: Advantages of minimally invasive total hip arthroplasty (THA) are controversially discussed.
METHOD: In this prospective study 51 patients (52 hips) were randomly allocated to a classical lateral or a minimally invasive approach (modification of the Hardinge-approach). Operating time, intraoperative blood loss, postoperative hemoglobin, muscle enzymes CK and myoglobin were recorded. Radiologically the positioning of the prosthesis was analyzed. WOMAC- and Harris Hip Score (HHS) were assessed preoperatively, at discharge, at 6 weeks and 3 months.
RESULTS: In the minimally invasive group there was a shorter length of surgery, the scores in the WOMAC and HHS were slightly better at discharge and at the 3 months- examination, myoglobin-rise was slightly less. The positioning of the prosthesis was good in both groups. Minimally invasive THA led to a quicker recovery, at 3 months postoperative there was still a slight difference to the standard group.
CONCLUSION: If these slight differences subside has to be examined in studies with a longer follow-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424709     DOI: 10.1007/s00402-009-0870-4

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  19 in total

1.  [Postoperative rehabilitation after minimally invasive total hip arthroplasty].

Authors:  J Heisel
Journal:  Orthopade       Date:  2012-05       Impact factor: 1.087

2.  [Minimally invasive total hip arthroplasty - trend or state of the art?: A meta-analysis].

Authors:  T Kappe; R Bieger; D Wernerus; H Reichel
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

3.  Is limited incision better than standard total hip arthroplasty? A meta-analysis.

Authors:  Joseph T Moskal; Susan G Capps
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

4.  [Modified mini-Hardinge access for hip prosthesis implantation in the supine position].

Authors:  F Mazoochian; F Schmidutz; A Fottner; V Jansson
Journal:  Oper Orthop Traumatol       Date:  2014-04-03       Impact factor: 1.154

5.  Reduced postoperative pain in total hip arthroplasty after minimal-invasive anterior approach.

Authors:  Sascha Goebel; Andre F Steinert; Judith Schillinger; Jochen Eulert; Jens Broscheit; Maximilian Rudert; Ulrich Nöth
Journal:  Int Orthop       Date:  2011-05-25       Impact factor: 3.075

6.  Greater trochanter fractures in the direct anterior approach: evolution during learning curve, risk factors and consequences.

Authors:  Constant Foissey; Raymond Kenney; Francesco Luceri; Elvire Servien; Sébastien Lustig; Cécile Batailler
Journal:  Arch Orthop Trauma Surg       Date:  2021-01-08       Impact factor: 3.067

Review 7.  [Minimally invasive surgery in total hip arthroplasty : Surgical technique of the future?].

Authors:  M Wörner; M Weber; P Lechler; E Sendtner; J Grifka; T Renkawitz
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

8.  Comparison of minimally invasive approach versus conventional anterolateral approach for total hip arthroplasty: a randomized controlled trial.

Authors:  T Repantis; T Bouras; P Korovessis
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-02-21

Review 9.  Minimally invasive and computer-navigated total hip arthroplasty: a qualitative and systematic review of the literature.

Authors:  Inge H F Reininga; Wiebren Zijlstra; Robert Wagenmakers; Alexander L Boerboom; Bregtje P Huijbers; Johan W Groothoff; Sjoerd K Bulstra; Martin Stevens
Journal:  BMC Musculoskelet Disord       Date:  2010-05-17       Impact factor: 2.362

Review 10.  [Clinical results of minimally invasive total hip arthroplasty].

Authors:  J Jung; K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2012-05       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.